Isabella M. Montagner

Padova, 35128, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

The Feasibility and Diagnostic Adequacy of PD-L1 Expression Analysis Using the Cytoinclusion Technique in Bladder Cancer: A Prospective Single-Center Study.

The Feasibility and Diagnostic Adequacy of PD-L1 Expression Analysis Using the Cytoinclusion Technique in Bladder Cancer: A Prospective Single-Center Study.

Journal: Journal of clinical medicine

Published: May 16, 2024

The Role of Checkpoint Inhibitor Expression Directly on Exfoliated Cells from Bladder Cancer: A Narrative Review.

The Role of Checkpoint Inhibitor Expression Directly on Exfoliated Cells from Bladder Cancer: A Narrative Review.

Journal: Diagnostics (Basel, Switzerland)

Published: July 18, 2023

p53/TP53 Status Assessment in Gastroesophageal Adenocarcinoma.

p53/TP53 Status Assessment in Gastroesophageal Adenocarcinoma.

Journal: Cancers

Published: March 31, 2023

Putative Clinical Potential of ERBB2 Amplification Assessment by ddPCR in FFPE-DNA and cfDNA of Gastroesophageal Adenocarcinoma Patients.

Putative Clinical Potential of ERBB2 Amplification Assessment by ddPCR in FFPE-DNA and cfDNA of Gastroesophageal Adenocarcinoma Patients.

Journal: Cancers

Published: March 10, 2022

PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB "Super-Stimulation".

PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB "Super-Stimulation".

Journal: Frontiers in oncology

Published: May 11, 2021

Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines.

Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines.

Journal: Cellular & molecular immunology

Published: September 03, 2020

Labelled micelles for the delivery of cytotoxic Cu(II) and Ru(III) compounds in the treatment of aggressive orphan cancers: Design and biological in vitro data.

Labelled micelles for the delivery of cytotoxic Cu(II) and Ru(III) compounds in the treatment of aggressive orphan cancers: Design and biological in vitro data.

Journal: Journal of inorganic biochemistry

Published: June 27, 2020

Anti-PSMA CAR-engineered NK-92 Cells: An Off-the-shelf Cell Therapy for Prostate Cancer.

Anti-PSMA CAR-engineered NK-92 Cells: An Off-the-shelf Cell Therapy for Prostate Cancer.

Journal: Cells

Published: May 14, 2020

A non-covalent antibody complex for the delivery of anti-cancer drugs.

A non-covalent antibody complex for the delivery of anti-cancer drugs.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: April 04, 2019

Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells.

Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells.

Journal: Cell death and differentiation

Published: November 25, 2017

Rational design of polyarginine nanocapsules intended to help peptides overcoming intestinal barriers.

Rational design of polyarginine nanocapsules intended to help peptides overcoming intestinal barriers.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: December 07, 2016

A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors.

A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors.

Journal: Oncoimmunology

Published: November 17, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026